Molecular analysis of patients with weak D and serologic analysis of those with anti-D (excluding type 1 and type 2)

Immunohematology

Volumn 29, Issue 2, 2013, Pages 55-62

  Pham, Bach Nga ^a   Roussel, Michèle ^a   Gien, Dominique ^a   Ripaux, Maryline ^a   Auxerre, Carine ^a   Le Pennec, Pierre Yves ^a   Andre Botte, Christine ^b  

^a INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

^b ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

Anti D; D variant; Partial D; RHD molecular analysis; Weak D

Indexed keywords

ALLOANTIBODY; BLOOD GROUP RHESUS SYSTEM;

ALLELE; BLOOD; BLOOD GROUP RHESUS SYSTEM; DNA SEQUENCE; ERYTHROBLASTOSIS, FETAL; FEMALE; GENE FREQUENCY; GENETICS; HUMAN; MALE; PREGNANCY;

ALLELES; ERYTHROBLASTOSIS, FETAL; FEMALE; GENE FREQUENCY; HUMANS; ISOANTIBODIES; MALE; PREGNANCY; RH-HR BLOOD-GROUP SYSTEM; SEQUENCE ANALYSIS, DNA;

EID: 84891505582     PISSN: 0894203X     EISSN: 19303955     Source Type: Journal    
DOI: 10.21307/IMMUNOHEMATOLOGY-2019-125     Document Type: Article

References (30)

1. Klein HG, Anstee DJ. Mollison's blood transfusion in clinical medicine. 11th ed. Malden, MA: Blackwell Publishing Ltd, 2005.
2. Liu W, Avent ND, Jones JW, Scott ML, Voak D. Molecular configuration of Rh D epitopes as defined by site-directed mutagenesis and expression of mutant Rh constructs in K562 erythroleukemia cells. Blood 1999;94:3986-96.
3. Scott ML, Voak D, Liu W, Jones JW, Avent ND. Epitopes on Rh proteins. Vox Sang 2000;78(Suppl 2):117-20.
4. Issitt PD, Anstee DJ. Applied blood group serology. 4th ed. Miami, FL: Montgomery Scientific Publications, 1998.
5. Frohn C, Dümbgen L, Brand JM, Görg S, Luhm J, Kirchner H. Probability of anti-D development in D- patients receiving D+ RBCs. Transfusion 2003;43:893-8.
6. Yazer MH, Triulzi DJ. Detection of anti-D in D- recipients transfused with D+ red blood cells. Transfusion 2007;47:2197-201.
7. Gonzalez-Porras JR, Graciani IF, Perez-Simon JA, et al. Prospective evaluation of a transfusion policy of D+ red blood cells into D- patients. Transfusion 2008;48:1318-24.
8. Daniels G. Human blood groups. 2nd ed. Oxford, UK: Blackwell Science; 2002.
9. Wagner FF, Gassner C, Müller TH, Schönitzer D, Schunter F, Flegel WA. Molecular basis of weak D phenotypes. Blood 1999;93:385-93.
10. Wagner FF. RhesusBase, version 2.0. Available at http://www.uni-ulm.de/%7Efwagner/RH/RB/. Accessed February 14, 2013.
11. Stratton F. New Rh alleomorph. Nature 1946;158:25-8.
12. Wagner FF, Frohmajer A, Ladewig B, et al. Weak D alleles express distinct phenotypes. Blood 2000;95:2699-708.
13. McGann H, Wenk RE. Alloimmunization to the D antigen by a patient with weak D type 21. Immunohematology 2010;26: 27-9.
14. Flegel WA. How I manage donors and patients with a weak D phenotype. Curr Opin Hematol 2006;13:476-83.
15. Pham BN, Roussel M, Peyrard T, et al. Anti-D investigations in individuals expressing weak D type 1 or weak D type 2: allo- or autoantibodies? Transfusion 2011;51:2679-85.
16. Ansart-Pirenne H, Asso-Bonnet M, Le Pennec PY, Roussel M, Patereau C, Noizat-Pirenne F. RhD variants in Caucasians: consequences for checking clinically relevant alleles. Transfusion 2004;44:1282-6.
17. Legler TJ, Maas JH, Köhler M, et al. RHD sequencing: a new tool for decision making on transfusion therapy and provision of Rh prophylaxis. Transfus Med 2001;11:383-8.
18. Noizat-Pirenne F, Lee K, Le Pennec P-Y, et al. Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safety. Blood 2002;100: 4223-31.
19. International Society of Blood Transfusion (ISBT). Blood group allele terminology. Available at http://www.isbtweb.org/working-parties/red-cell-immunogenetics-and-blood-groupterminology/blood-group-terminology/blood-group-allele-terminology/. Accessed February 14, 2013.
20. Hemker MB, Ligthart PC, Berger L, van Rhenen DJ, van der Schoot CE, Wijk PA. DAR, a new RhD variant involving exons 4, 5, and 7, often in linkage with ceAR, a new Rhce variant frequently found in African blacks. Blood 1999;94:4337-42.
21. Wagner FF, Frohmajer A, Flegel WA. RHD positive haplotypes in D negative Europeans. BMC Genet 2001;2:10-24.
22. Flegel WA, Wagner FF. Molecular biology of partial D and weak D: implications for blood bank practice. Clin Lab 2002;48: 53-9.
23. Müller TH, Wagner FF, Trockenbacher A, et al. PCR screening for common weak D types shows different distributions in three Central European populations. Transfusion 2001;41: 45-52.
24. Le Maréchal C, Guerry C, Benech C, et al. Identification of 12 novel RHD alleles in western France by denaturing high-performance liquid chromatography analysis. Transfusion 2007;47:858-63.
25. Christiansen M, Samuelsen B, Christiansen L, Morbjerg T, Bredahl C, Grunnet N. Correlation between serology and genetics of weak D types in Denmark. Transfusion 2008;48:187-93.
26. Flegel WA. Blood group genotyping in Germany. Transfusion 2007;47(1 Suppl):47S-53S.
27. Chen Q, Flegel WA. Random survey for RHD alleles among D+ European persons. Transfusion 2005;45:1183-91.
28. Denomme GA, Wagner FF, Fernandes BJ, Li W, Flegel WA. Partial D, weak D types, and novel RHD alleles among 33,864 multiethnic patients: implications for anti-D alloimmunization and prevention. Transfusion 2005;45:1554-60.
29. Dogic V, Bingulac-Popovic J, Babic I, et al. Distribution of weak D types in the Croatian population. Transfus Med 2011;21:278-9.
30. Garratty G. Do we need to be more concerned about weak D antigens? Transfusion 2005;45:1547-51.